DECIMMUNE THERAPEUTICS INC — Form D
DECIMMUNE THERAPEUTICS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-16. The offering totals $2.2M, of which $1.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2013-01-16
- Form: D
- Accession: 0001376644-13-000001
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $2.2M
- Amount sold: $1.7M
- Remaining: $500K
- Investors: 3
- Date of first sale: 2013-01-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-190385
Issuer
- Name: DECIMMUNE THERAPEUTICS INC
- CIK: 0001376644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: C/O HEALTHCARE VENTURES, CAMBRIDGE, MA, 02141
- Phone: 617-278-6655
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael C Carroll, Ph.D. | Director | Cambridge, MA |
| Richard S Foemmel, Ph.D. | Director | Cambridge, MA |
| Christopher K Mirabelli, Ph.D. | Director | Cambridge, MA |
| Harold R Werner | Director | Malvern, PA |
| Lewis J Geffen | Executive Officer | Boston, MA |
| Christopher K Mirabelli, Ph.D. | Executive Officer | Cambridge, MA |
| Janis C Naeve, Ph.D. | Director | Cambridge, MA |
| Lewis K Geffen | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More